Read More Pharma Industry News Merus N.V. stock soars on breakthrough cancer trial: What drove MRUS to the top gainers list? Merus N.V. stock jumped 32% on breakthrough cancer trial data. Find out what’s driving MRUS and what could come next for this biotech leader. byPallavi MadhirajuMay 24, 2025